Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Finasteride worsens stress effects on sensory processes, possibly linking to anxiety/depression.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Ovulation disorders are a major cause of infertility and menstrual problems in women.

GLP-1 agonists may help treat certain skin conditions.

Adaptive coping reduces PCOS symptoms, while maladaptive coping worsens them.

Lifestyle changes can significantly improve hair loss in overweight women with PCOS.

ADAM17 could be a potential target for treating PCOS.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

Artemis dysfunction might cause hair loss through telomere shortening.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

PCOS is likely inherited in families, increasing risk for first-degree relatives.

The document concludes that proper diagnosis and treatment of hair shaft disorders require understanding their unique causes and avoiding hair-damaging practices.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Cholesterol transport in hair follicles decreases from growth to regression phase.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

The conclusion is that the nuclear lamina and LINC complex in skin cells respond to mechanical signals, affecting gene expression and cell differentiation, which is important for skin health and can impact skin diseases.